Evidence map›Paper›PMID 24058536›Full record

ArticlePloS one2013

Pathogenic mouse hepatitis virus or poly(I:C) induce IL-33 in hepatocytes in murine models of hepatitis.

Muhammad Imran Arshad, Solène Patrat-Delon, Claire Piquet-Pellorce, Annie L'helgoualc'h, Michel Rauch, Valentine Genet, Catherine Lucas-Clerc, Christian Bleau, Lucie Lamontagne, Michel Samson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. CXCL14 Chemokine Exacerbates Acute Viral Hepatitis in Coronavirus MHV-Infected Mice and Is Associated With Human Acute Viral Hepatitis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Muhammad Imran ArshadInstitut de Recherche Santé Environnement et Travail (IRSET) - U.1085, Institut National de la Santé et de la Recherche Médicale (Inserm), Rennes, Bretagne, France ; Université de Rennes 1, Rennes, Bretagne, France ; Structure Fédérative BioSit UMS 3480 CNRS-US18 Inserm, Rennes, Bretagne, France ; Institute of Microbiology, University of Agriculture, Faisalabad, Pakistan.
Solène Patrat-Delon
Claire Piquet-Pellorce
Annie L'helgoualc'h
Michel Rauch
Valentine Genet
Catherine Lucas-Clerc
Christian Bleau
Lucie Lamontagne
Michel Samson
Structure Fédérative de Recherche en Biologie et Santé de Rennes · FRUniversité du Québec à Montréal · CAFédération de recherche en imagerie multi-modalitéInserm · FRInstitut de Recherche en Santé, Environnement et Travail · FRUniversité de Rennes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The IL-33/ST2 axis is known to be involved in liver pathologies. Although, the IL-33 levels increased in sera of viral hepatitis patients in human, the cellular sources of IL-33 in viral hepatitis remained obscure. Therefore, we aimed to investigate the expression of IL-33 in murine fulminant hepatitis induced by a Toll like receptor (TLR3) viral mimetic, poly(I:C) or by pathogenic mouse hepatitis virus (L2-MHV3). The administration of poly(I:C) plus D-galactosamine (D-GalN) in mice led to acute liver injury associated with the induction of IL-33 expression in liver sinusoidal endothelial cells (LSEC) and vascular endothelial cells (VEC), while the administration of poly(I:C) alone led to hepatocyte specific IL-33 expression in addition to vascular IL-33 expression. The hepatocyte-specific IL-33 expression was down-regulated in NK-depleted poly(I:C) treated mice suggesting a partial regulation of IL-33 by NK cells. The CD1d KO (NKT deficient) mice showed hepatoprotection against poly(I:C)-induced hepatitis in association with increased number of IL-33 expressing hepatocytes in CD1d KO mice than WT controls. These results suggest that hepatocyte-specific IL-33 expression in poly(I:C) induced liver injury was partially dependent of NK cells and with limited role of NKT cells. In parallel, the L2-MHV3 infection in mice induced fulminant hepatitis associated with up-regulated IL-33 expression as well as pro-inflammatory cytokine microenvironment in liver. The LSEC and VEC expressed inducible expression of IL-33 following L2-MHV3 infection but the hepatocyte-specific IL-33 expression was only evident between 24 to 32h of post infection. In conclusion, the alarmin cytokine IL-33 was over-expressed during fulminant hepatitis in mice with LSEC, VEC and hepatocytes as potential sources of IL-33.

Indexed as

AnimalsAntigens, CD1dEndothelial CellsEndothelium, VascularGalactosamineGene DeletionGene ExpressionHepatitisHepatitis, Viral, AnimalInterleukin-33InterleukinsKiller Cells, NaturalLiverMiceMice, KnockoutMurine hepatitis virusAntigens, CD1dCD1d antigen, mouseGalactosamineIl33 protein, mouseInterleukin-33InterleukinsPoly I-C

Identifiers

PMID24058536
PMCPMC3772926
OpenAlexW2086746877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.